Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Shennon Biotechnologies
2325 3rd Street, Suite 298
San Francisco, CA 94107
https://www.shennonbio.com/

Founded in 2021, ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level within a few hours, enabling the identification of TCR or antibody targets to develop more precise and effective immunotherapies.

Key Contact
Name
Li Sun
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
03/13/23 $13,000,000 Seed AV8 Ventures
DCVC
Foundation Capital
undisclosed